“…Of the 11 identified depletion target proteins in NT OF, all were quantified at 90% reduced expression following EMD; 32 upregulated proteins, with twofold or more increased expression, were detected following EMD. Four of these showed a 100-fold increase in expression: 1) a 78-kDa glucose-regulated protein; this protein is an ER chaperone which regulates protein folding; it is known to be upregulated during embryonic cardiac development [22], and highly upregulated in a variety of cancer specimens, including breast cancer, lung cancer, liver cancer and prostate cancer [23][24][25]; 2) 14-3-3 epsilon protein is a regulatory factor, involved in signal transduction activity; it's expression level is known to be upregulated in head and neck squamous cell carcinoma [26], Alzheimer's disease and Down syndrome patients; 3) leukotriene A-4 hydrolase is a bifunctional zinc enzyme with epoxide hydrolase and aminopeptidase activities; this low-abundance OF protein was first visualized in 2-DE following TD OF, as we previously published [10], and here it presented a higher expression level following EMD; it is known to increase significantly in human atherosclerotic plaque [27]; in addition, its overexpression seems to be an early event in esophageal adenocarcinogenesis and it has been suggested as a potential target for the chemoprevention of esophageal adenocarcinogenesis [28]; 4) vitamin D-binding (DBP) protein is a carrier protein used for solubilization and transport of vitamin D and its metabolites in the serum; many studies have discussed the link between DBP phenotypes and susceptibility or resistance to osteoporosis, Graves' disease [29], Hashimoto's thyroiditis [30], diabetes [31][32][33] COPD [34,35], AIDS [36], multiple sclerosis [37], sarcoidosis [38] and rheumatic fever [30,39].…”